WallStreetZenWallStreetZen

NASDAQ: ALVO
Alvotech Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ALVO past revenue growth

How has ALVO's revenue growth performed historically?
Company
-33.69%
Industry
11.19%
Market
13.97%
ALVO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ALVO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ALVO earnings and revenue history

Current Revenue
$63.7M
Current Earnings
-$595.7M
Current Profit Margin
-934.4%

ALVO Return on Equity

Current Company
N/A
Current Industry
11.5%
Current Market
-9.5%

Be the first to know when ALVO announces earnings.

ALVO Return on Assets

Current Company
-66.3%
Current Industry
3.4%
ALVO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ALVO Return on Capital Employed

Current Company
-59.45%
Current Industry
6.2%

ALVO vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ALVO$63.75M-$436.20M-$595.68M+367.33%N/A
BHC$8.54B$1.84B-$963.00M+0.28%N/A
AMPH$601.31M$216.41M$135.29M+17.77%+26.20%
INDVN/AN/AN/AN/AN/A
PBH$1.13B$17.26M-$81.77M+2.02%N/A
View Top Pharmaceutical Stocks

Alvotech Earnings & Revenue FAQ

What were ALVO's earnings last quarter?

On Invalid Date, Alvotech (NASDAQ: ALVO) reported Q3 2023 earnings per share (EPS) of -$0.82, up 4,200% year over year. Total Alvotech earnings for the quarter were -$188.32 million. In the same quarter last year, Alvotech's earnings per share (EPS) was $0.02.

If you're new to stock investing, here's how to buy Alvotech stock.

What was ALVO's earnings growth in the past year?

As of Q4 2023, Alvotech's earnings has grown year over year. Alvotech's earnings in the past year totalled -$595.68 million.

What was ALVO's revenue last quarter?

On Invalid Date, Alvotech (NASDAQ: ALVO) reported Q3 2023 revenue of $17.80 million up 6.85% year over year. In the same quarter last year, Alvotech's revenue was $19.11 million.

What was ALVO's revenue growth in the past year?

As of Q4 2023, Alvotech's revenue has grown -33.69% year over year. This is 44.87 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 11.19%. Alvotech's revenue in the past year totalled $63.75 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.